• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Dan Vasella makes some cash!!!

Anonymous

Guest
Once again, the pay package given Novartis chairman Dan Vasella is causing a ruckus. At the annual meeting yesterday in Basel, Switzerland, only 61 percent of shareholders backed the compensation plan, the first time remuneration was put to a vote. This is not considered a very good showing, however, and in fact, Dan and Novartis ceo Joe Jimenez were criticized for their salaries and because a chunk of their pay is not tied to long-term performance, The Wall Street Journal writes.
So what did Dan receive? According to the Novartis annual report, he earned about $8.5 million last year, including cash and stock. Separately, Dan also received a one-time retirement benefit worth $12.8 million. But Ethos, a shareholder activist organization, calculates he earned around $27 million. And Rudolf Meyer, who heads the Actares activist group, called Vasella’s retirement package “scandalous.” The ISS proxy advi
 




Why are you complaining? Didn't I give you all Blackberries!

You got a phone, I got 27 Million, that sounds fair to me.

Now get back to work while I fly the company jet to Italy for the weekend.

Love Dan xoxo